Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Other Non-Current Assets (2020 - 2025)

Historic Other Non-Current Assets for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to $4.5 million.

  • Cytek Biosciences' Other Non-Current Assets fell 991.92% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year decrease of 991.92%. This contributed to the annual value of $4.8 million for FY2024, which is 4059.08% up from last year.
  • Per Cytek Biosciences' latest filing, its Other Non-Current Assets stood at $4.5 million for Q3 2025, which was down 991.92% from $4.7 million recorded in Q2 2025.
  • In the past 5 years, Cytek Biosciences' Other Non-Current Assets registered a high of $5.0 million during Q3 2024, and its lowest value of $1.3 million during Q2 2021.
  • Over the past 5 years, Cytek Biosciences' median Other Non-Current Assets value was $3.3 million (recorded in 2023), while the average stood at $3.4 million.
  • As far as peak fluctuations go, Cytek Biosciences' Other Non-Current Assets surged by 25150.35% in 2022, and later tumbled by 3051.11% in 2023.
  • Cytek Biosciences' Other Non-Current Assets (Quarter) stood at $1.7 million in 2021, then skyrocketed by 77.6% to $3.0 million in 2022, then grew by 14.47% to $3.4 million in 2023, then soared by 40.59% to $4.8 million in 2024, then fell by 6.3% to $4.5 million in 2025.
  • Its Other Non-Current Assets stands at $4.5 million for Q3 2025, versus $4.7 million for Q2 2025 and $4.6 million for Q1 2025.